ANALGESICS IN COSTA RICA

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Brand Recognition, Pricing and Usage Tradition Continue To Set the Pace During 2018

New Molecular Breakthroughs and Combination Formulas Are Anticipated

Competitive Landscape

Traditional International Players Remain Ahead in Value Sales

Less-traditional Players Including Producers of Local Brands and Generics Keep Gaining Shelf Space

Scale Logistics and Point-of-sale Loyalty Schemes Are Anticipated To Gain Momentum

Category Data

Table 1 Sales of Analgesics by Category: Value 2013-2018

Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018

Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018

Table 4 NBO Company Shares of Analgesics: % Value 2014-2018

Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018

Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023

Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Executive Summary

Healthier Lifestyle Approaches Continue To Leverage on New Dietary Trends, Influencing Consumer Health Demand During 2018

Additional Segmentation and Lower-priced Generics Set the Pace of 2018's Value Sales Performance

Traditional International Pharmaceuticals Maintain Their Competitive Advantages During 2018

Distribution Efforts Continue To Target Modern Grocery Retailers and Healthcare Specialists, While Players Make Room for Online Sales Opportunities

New Lifestyle and Dietary Habits Are Anticipated To Continue Influencing Consumer Health's Performance Over the Forecast Period

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Definitions

Sources

Summary 1 Research Sources

As seen across most mass-consumption categories in Costa Rica, top-of-mind recognition, availability and affordable pricing continued to set the pace in local analgesics sales during the 2017-2018 period, particularly in the case of the more-specialised, value-added options found across pharmacies and drugstores. Most OTC analgesics were given point-of-sale activation campaigns, which kept promoting specific brands, as a result of the interaction between manufacturers and store staff/pharmacists...

Euromonitor International's Analgesics in Costa Rica report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.